{
    "clinical_study": {
        "@rank": "9744", 
        "arm_group": [
            {
                "arm_group_label": "Subjects who have no mammographically detectable tumors", 
                "description": "This group will be evaluated for marker presence in NAF. no drugs administered"
            }, 
            {
                "arm_group_label": "Subjects who have non-cancerous growths", 
                "description": "This group will be evaluated to study whether marker(s) detected in NAF are also expressed in non-cancerous tumors. No drugs administered"
            }, 
            {
                "arm_group_label": "subjects who have cancerous growths", 
                "description": "In this group, any markers detected in NAF could also be detected in tumor tissues. No drugs administered."
            }
        ], 
        "brief_summary": {
            "textblock": "This will be a Phase I study. During the Phase I study, our goals are: 1) screen a number of\n      cancer biomarkers in Nipple Aspirate Fluid (NAF) from women who have no mammographically\n      detectable tumors, and those who have detectable tumors, 2) identify all the detectable\n      markers and 3) establish that biomarkers detected in NAF could also be detected in the\n      biopsied tumor tissue that was removed for diagnostic purpose in subjects who have\n      detectable tumors."
        }, 
        "brief_title": "Biomarker Breast Pap Test", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Tumors", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Any female subject aged 18 years or older\n\n        Exclusion Criteria:\n\n          -  none"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Any woman age 18 or older"
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 7, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01683305", 
            "org_study_id": "Silbiotech:2012-01"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "biomarker,", 
            "NAF", 
            "Subjects"
        ], 
        "lastchanged_date": "September 10, 2012", 
        "number_of_groups": "3", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01683305"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Silbiotech", 
            "investigator_full_name": "Indira Poola, Ph.D", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Silbiotech", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Silbiotech", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Observational Model: Cohort", 
        "study_type": "Observational", 
        "verification_date": "September 2012"
    }
}